Clinical Trial Opportunity for Adults with Non-radiographic Axial Spondyloarthritis (nr-axSpA)

By Spondylitis Association of America

Tuesday, January 09, 2018

The following is an announcement from SAA about a third party clinical trial. SAA is not affiliated with this study, the researchers, or the drug manufacturer.


A phase 3 clinical trial is now recruiting non-radiographic axial Spondyloarthritis (nr-axSpA) patients over the age of 18 to participate in a study of an investigational biologic medication, secukinumab, given by injection.

You may qualify to participate in this study if you:

  • • Are 18 years of age or older
  • • Have been diagnosed with nr-axSpA
  • • Have no radiographic evidence of changes in the sacroiliac joints
  • • Have had little or no relief from prescription anti-inflammatory medications
  • • First experienced symptoms before age 45
  • • Have had inflammatory back pain for at least six months

Additional requirements apply.

If you qualify and agree to be in the study, you will receive the investigational study medication and all study-related care at no cost. Participation is expected to last approximately 24 months.

The purpose of the trial, entitled the “Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis,” is to evaluate the safety, tolerability, and effectiveness of the injected investigational study medication, secukinumab, in helping to decrease the frequency and severity of spondyloarthritis symptoms.

More information can be found at

This study is sponsored by Novartis Pharmaceuticals. For location of study centers near you, you can contact them at 1-888-669-6682 and ask for NCT02696031.

Learn more about participating in Clinical Studies


Stay Informed



Visit our careers page for available positions

Contact Us

Spondylitis Association of America

16360 Roscoe Blvd.  Ste. 100
Van Nuys, CA 91406


Information Requests

(800) 777-8189 U.S. only
or (818) 892-1616
*Please note: This is not a Crisis Hotline. If you are in a life-threatening crisis, please dial 911 for immediate help in the US. Please follow this link for crisis intervention resources.

Give With Confidence